Metadata from OpenAlexLast checked: Sep 26, 2026

Cardio-Oncology — Journal Profile & Submission Links

BioMed Central · ISSN-L 2057-3804

Cardio-Oncology publishes articles in cardiology.

Listed metrics: Q2, open access, OpenAlex 2-year citedness 2.27.

Authors checking fit can use the scope note and the official links on this profile.

→ Check whether your manuscript fits this journal, free

This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.

Official links

Publisher
BioMed Central
Publisher country
United Kingdom
Open access
Yes
Listed in DOAJ
Yes
APC (USD)
2,790 USD
Works count
600
Cited-by count
4466
OpenAlex 2-year mean citedness
2.27
Quartile
Q2

The journal's own scope statement

The text below is the catalog scope statement for this journal.

The mission of Cardio-Oncology is to promote the science, technology, practice, and betterment of the public health of the emerging field of cardio-oncology. We are an international, open access journal that strives to publish original, important, valid, peer-reviewed articles on a diverse range of medical topics related to cardiovascular effects of cancer treatments. The journal welcomes submissions related to the pathophysiology, prevention, diagnosis, and treatment of the effects of cancer therapies, from basic mechanistic studies, to translational, preclinical and clinical research, including clinical trials, outcomes studies, case reports, and imaging techniques. Topical areas include, but are not limited to: Preclinical and clinical mechanisms of the cardiotoxicity of anticancer drugs; Biomarkers and the susceptibility of cancer patients to cardiovascular injury; Cancer treatment for patients with a cardiovascular history; Monitoring and detection of patients at risk of cardiotoxicity; Prevention and treatment strategies, such as dose changes for chemotherapy; Cardiovascular care for cancer survivors; Quality, safety, human factors and reliability of cancer care; Health systems design and strengthening. Cardio-Oncology is the premier journal devoted exclusively to this emerging specialty, providing an international forum for elevating the quality of medical care, disease prevention, and research via state-of-the-art reviews, filling a critical gap in the science and clinical practice of this important field. The journal serves to inform readers about the various aspects of cardio-oncology medicine and public health, including cultural, sociopolitical, ethical, legal, environmental, economic, structural, and historical issues. We are committed to producing a high impact and credible publication that is timely and enjoyable to read.

Catalog source: scimago. This is not a copy of the publisher's author instructions.

For review time and acceptance rate, see the journal's official author guidelines. cardiooncologyjournal.biomedcentral.com/submission-guideline…

General pre-submission checks for medical manuscripts

Generic checklist only — not journal-specific requirements.

  • Confirm scope fit and intended article type on the official journal site.
  • Abstract structure matches the journal's current requirements.
  • Ethics approval and trial registration statements are complete.
  • Informed consent and patient privacy statements are in place.
  • Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
  • Reference style and citation limits per official guidelines.
  • Figures and tables meet resolution, labeling, and count limits.
  • Cover letter addresses novelty, fit, and required declarations.
  • Conflicts of interest statement included.
  • Funding statement included.
  • Data availability statement included when required.

FAQ